Apellis Pharmaceuticals (APLS) PT Lowered to $60 at Stifel

February 28, 2025 3:25 PM

Stifel analyst Annabel Samimy lowered the price target on Apellis Pharmaceuticals (NASDAQ: APLS) to $60.00 (from $75.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found